Reduced transdermal absorption of N,N-diethyl-m-toluamide from a new topical insect repellent formulation

Pharmaceutical Development and Technology
H QiuJ McCall

Abstract

Extensive absorption of the topical insect repellent N, N-diethyl-m-toluamide (DEET) causes systemic and local toxicities. This report describes the preparation and characterization of a new insect repellent formulation (FA), a PEG-polyacrylic acid polymer system, for its DEET release, in vitro skin permeation, and in vivo transdermal absorption properties; and for its relative repellency against Aedes aegypti mosquitoes. DEET release and skin permeation were studied in Franz diffusion cells. DEET transdermal absorption and relative repellency of FA were assessed in beagle dogs. A commercial DEET lotion (FB) and technical DEET (FC) were used as references. FA exhibited 19.5% and 61.7% decrease in DEET steady-state skin flux compared with FB and FC, respectively. At 15 mg DEET/kg, the absolute DEET transdermal bioavailability and Cmax were 13.4% and 154.3 ng/ml, respectively, for FA; and were 17.5% and 196.5 ng/ml, respectively, for FB. DEET half-lives (t1/2) for FA (2.52 hr) and FB (2.73 hr) were similar, while MRT for FA (4.99 hr) was significantly greater (p < 0.05) than that for FB (4.38 hr). FA showed lower mosquito biting rates at 1, 2, 3, 4, 5, and 6 hr postdose at 0.5 mg DEET/cm2. FA exhibited reduced in vitro skin perme...Continue Reading

References

Mar 1, 1992·Annals of Emergency Medicine·J W LipscombJ B Leikin
Jan 1, 1986·Journal of Toxicology and Environmental Health·P J Robbins, M G Cherniack
May 1, 1986·Antimicrobial Agents and Chemotherapy·D J FreemanS L Spruance
May 1, 1970·The Journal of Investigative Dermatology·R J Feldmann, H I Maibach
Aug 1, 1982·Archives of Dermatology·H Reuveni, P Yagupsky
Oct 1, 1982·American Industrial Hygiene Association Journal·H L SnodgrassM H Weeks
May 1, 1995·The Journal of Pharmacy and Pharmacology·C H LiuM T Sheu
Mar 1, 1993·The Annals of Pharmacotherapy·J R ClemM A Raebel
Nov 1, 1996·Journal of Pharmaceutical and Biomedical Analysis·H Qiu, H W Jun
Feb 9, 1961·The New England Journal of Medicine·J GRYBOSKIN K ORDWAY
Oct 1, 1961·Journal of Pharmaceutical Sciences·T HIGUCHI
Aug 1, 1986·Pharmaceutical Research·K I Al-KhamisJ Hadgraft

❮ Previous
Next ❯

Citations

Dec 18, 2003·Journal of Toxicology. Clinical Toxicology·Daniel L Sudakin, Wade R Trevathan
Aug 14, 2020·Regulatory Toxicology and Pharmacology : RTP·N B HopfA L Bunge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.